John Hiemenz

University of Florida — United States

Medicine · Health Sciences

15h-index3.3kcitations34works0.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neutropenia and Cancer Infections(10), Hematopoietic Stem Cell Transplantation(7), Multiple Myeloma Research and Treatments(7), Acute Myeloid Leukemia Research(5), Hematological disorders and diagnostics(5)

Publications34 total

Randomized Noninferiority Trial of a Liberalized Diet Versus the Neutropenic Diet in Hematopoietic Stem-Cell Transplant Patients and Patients With Acute Leukemia
Journal of Clinical Oncology·2025· 1 cited
An open-label, multi-center Phase 2 study to assess the safety and efficacy of burixafor (GPC-100) and propranolol with G-CSF for the mobilization of hematopoietic progenitor cells in patients with multiple myeloma
Blood·2025· 1 citedOpen Access
CTIM-21. FIRST-IN-HUMAN PHASE I CLINICAL TRIAL USING 8R-70CAR T CELLS FOR NEWLY DIAGNOSED ADULT GLIOBLASTOMA
Neuro-Oncology·2024· 1 citedOpen Access
A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia
Leukemia & lymphoma/Leukemia and lymphoma·2024· 2 cited
Motixafortide Enables Consistent, Robust Hematopoietic Stem Cell Collection (HSC) across Populations with Increased Impaired HSC Mobilization: A Sub-Group Analysis of the Genesis Study
Transplantation and Cellular Therapy·2024
Prompt Autologous Hematopoietic Stem Cell Transplant in Patients with Large B-Cell Lymphoma Is Associated with Lower Rates of Progression of Disease Prior to Transplant
Transplantation and Cellular Therapy·2024
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial
Nature Medicine·2023· 69 citedOpen Access
TRANSTHYRETIN CARDIAC AMYLOIDOSIS DISGUISED AS LIGHT CHAIN AMYLOIDOSIS, OR MULTIPLE MYELOMA?
Journal of the American College of Cardiology·2023
A Phase III, Randomized Clinical Trial Comparing a Neutropenic Vs Liberalized Diets in Patients Undergoing Hematopoietic Stem Cell Transplant (HSCT) or Remission Induction Chemotherapy for Acute Leukemia/ Myelodysplastic Syndrome (MDS): Results of Interim Analysis
Transplantation and Cellular Therapy·2022
Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes
British Journal of Haematology·2020· 15 citedOpen Access
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation
Antimicrobial Agents and Chemotherapy·2020· 32 citedOpen Access
Absolute Lymphocyte Count Recovery Following Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Biology of Blood and Marrow Transplantation·2020Open Access
Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients
Hematology/Oncology and Stem Cell Therapy·2019· 17 citedOpen Access
Abstract CT085: iCare 1: A prospective clinical trial to predict treatment response based on mutanome-informed computational biology in patients with AML and MDS
Cancer Research·2017· 2 cited
Poor peripheral blood stem cell mobilization affects long‐term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation
Journal of Clinical Apheresis·2017· 42 cited
Icare 1: A Prospective Clinical Trial to Predict Treatment Response Based on Mutanome-Informed Computational Biology in Patients with AML and MDS
Blood·2016· 2 cited
Effect of melphalan 140 mg/m<sup>2</sup> vs 200 mg/m<sup>2</sup> on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation—a single center experience
Clinical Transplantation·2016· 19 cited
Community Acquired Respiratory Viral Infections (CARV) in Patients with Acute Leukemia and Hematopoietic Stem Cell Transplant (HSCT) Recipients
Biology of Blood and Marrow Transplantation·2016Open Access
Poor Peripheral Blood Stem Cell Mobilization Correlates with Worse Long-Term Outcomes in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Biology of Blood and Marrow Transplantation·2015Open Access
Association of Mannose Binding Lectin (MBL) Levels and Invasive Fungal Disease (IFD) in Hematologic Malignancy Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) or Receiving Chemotherapy
Biology of Blood and Marrow Transplantation·2013Open Access
page 1 of 2Next →

Frequent Co-authors

John R. Wingard(15), Jack W. Hsu(13), Christopher R. Cogle(9), Maxim Norkin(7), Randy A. Brown(6), Philip A. Pizzo(5), Nosha Farhadfar(5), Christina Cline(5), Thomas J. Walsh(4), Jan S. Moreb(4), W. Stratford May(4), James W. Hathorn(3), Janet Gress(3), D. Marshall(3), Jane Skelton(3), Michael Byrne(3), Randall W. Brown(3), Hemant S. Murthy(3), Zeina Al‐Mansour(3), Ji‐Hyun Lee(3)